Mercado mundial de agentes antitiroideos: tendencias de la industria y pronóstico hasta 2029

Análisis y tamaño del mercado de agentes antitiroideos

Se espera que el mercado mundial de agentes antitiroideos experimente un crecimiento significativo durante el período de pronóstico. La enfermedad de Graves es una de las principales causas de hipertiroidismo y la incidencia de la enfermedad de Graves está aumentando. Es más frecuente entre los 30 y los 60 años y se presenta en mujeres entre 5 y 10 veces más que en hombres. Los avances médicos que implican el descubrimiento continuo de fármacos y las iniciativas de organizaciones gubernamentales y no gubernamentales son lo que impulsa el crecimiento del mercado. COVID-19 también tuvo un impacto importante en el crecimiento del mercado.

Data Bridge Market Research analiza la tasa de crecimiento del mercado global de agentes antitiroideos en el período de pronóstico 2022-2029. La CAGR esperada del mercado global de agentes antitiroideos tiende a rondar el 3,50% en el período de pronóstico mencionado. El mercado se valoró en USD 2.3 mil millones en 2021 y crecería hasta USD 3.03 mil millones para 2029. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Definición de mercado

Los agentes antitiroideos son fármacos que previenen o inhiben la biosíntesis de la hormona tiroidea. Su uso más extendido es en el tratamiento de la hiperactividad tiroidea causada clínicamente por la enfermedad de Graves. Es de gran importancia para el sector sanitario y, por lo tanto, se espera que aumente en el período de pronóstico.

Alcance y segmentación del mercado de agentes antitiroideos

Global Antithyroid Agents Market Dynamics

Drivers

• Increased Incidence of Thyroid Disorders

Thyroid Disorders, mainly hyperthyroidism, affect 200 million people globally; in most countries, half of the population remains undiagnosed. This condition is more prevalent among women and the elderly. As per the statistics by the Thyroid Foundation of Canada in 2015, 1 in every 1700 children in Canada is affected by congenital hypothyroidism. This creates more opportunity in the market.

• Increased Initiatives by Government and Market Players

The increasing number of efforts and initiatives that are being initiated by the government and major market leaders all over the world are boosting the market growth. Governments in many countries have launched several healthcare schemes, which, a patient can use for the treatment of several disorders. Furthermore, hyperthyroidism is a serious issue, becoming the reason of mortality for people worldwide each year. Thus, these policies drive the market growth

Opportunities

• The Growing Strategic Collaborations

There has been an increase in collaborative agreements between private and public organizations that aids to spread awareness pertaining to thyroid management among healthcare professionals and patients is expected to expand the market growth. Several government organizations such as The British Thyroid Foundation, American Thyroid Association (ATA), American Academy of Otolaryngology and Thyroid Foundation of Canada are engaged in many promotional activities to create awareness regarding the disease and its treatment options.

• Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Restraints/Challenges

• Lack of Skilled Professionals

Lack of trained professionals who are unaware of the knowledge of the treatment methods for this disease could curb the growth of the global antithyroid agents market over a forecast period.

• Increasing Cost of Treatment

One of the primary factors that are causing a restrain to the antithyroid agents market is the high cost of the drugs associated with the disease. There is an increasing number of people that suffer from thyroid disorders all over the world. Most of the population cannot get the optimum benefit of the treatment due to the rising cost.  

This global antithyroid agents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global antithyroid agents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Antithyroid Agents Market       

Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials. Thyroidism is increasing irrespective of the COVID-19 situation but due to the pandemic, this was in halt.

But, in the post-pandemic era, the market is expected to flourish with the increasing upliftments of hospitals and clinics and the reduction of COVID-19 treatment methods.

Global Antithyroid Agents Market Scope

The global antithyroid agents market is segmented on the basis of drug, indication, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drugs

• Sodium Iodide-I-131
• Methimazole
• Others

Indication

• Hyperthyroidism
• Thyroid Cancer
• Others

End-Users

• Hospitals
• Homecare
• Speciality Centres
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Antithyroid Agents Market Regional Analysis/Insights

The global antithyroid agents market is analysed and market size insights and trends are provided by drug, indication, distribution channel and end-user as referenced above.

The major countries covered in the global antithyroid agents market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to the presence of advance healthcare infrastructure and high prevalence of thyroid diseases.

Asia-Pacífico domina el mercado debido al desarrollo económico y al aumento de las iniciativas gubernamentales.

La sección de países del informe también proporciona factores de impacto individuales en el mercado y cambios en la regulación del mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Además, se consideran la presencia y disponibilidad de marcas globales y los desafíos que enfrentan debido a la gran o escasa competencia de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales, al tiempo que se proporciona un análisis de pronóstico de los datos del país.   

Análisis del panorama competitivo y de la cuota de mercado global de los agentes antitiroideos

El panorama competitivo del mercado global de agentes antitiroideos proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento del producto, la amplitud y la variedad del producto, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado global de agentes antitiroideos.

Los actores clave que operan en el mercado global de agentes antitiroideos incluyen:

• Industrias farmacéuticas Teva Ltd (Israel)
• Mylan NV (Estados Unidos)
• Johnsons & Johnsons Services Inc (Estados Unidos)
• F. Hoffman-La Roche Ltd. (Suiza)
• Lilly (Estados Unidos)
• Merck & Co., Inc. (Estados Unidos)
• Aurobindo Pharma (India)
• CASI Pharmaceuticals Inc. (Estados Unidos)
• Compañía Bristol-Myers Squibb (Estados Unidos)
• GSK plc (Reino Unido)
• Aurobindo Pharma (India)
• Compañía farmacéutica Mission (EE. UU.)
• ECI Pharmaceuticals (Estados Unidos)

SKU-53997